Research and Development

RFK Jr. Terminates $500 Million in BARDA mRNA Vaccine Projects as Experts Warn of Consequences

HHS says data justify shifting from mRNA toward broader vaccine platforms, with replacement funding yet unspecified, prompting experts to decry readiness gaps